Alzheimer’s vaccine – First evidence for efficacy
Monday, March 14th, 2011AFFiRiS’ Alzheimer’s vaccine candidate AD02 showed indicative evidence for potential efficacy in a phase I clinical trial. This was demonstrated by the analysis of the data from secondary clinical study endpoints.
Go here to read the rest:
Alzheimer’s vaccine – First ... continue reading